119.44

6.01% 6.77

After Hours: 119.44

Irhythm Technologies Inc (IRTC)

Overview News Price History Option Chain Financials Discussions Forecast

Irhythm Technologies Inc stock is traded at $119.44, with a volume of 1.79M. It is up +6.01% in the last 24 hours and up +9.87% over the past month. iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.

Previous Close:

$112.67

Open:

$118.64

24h Volume:

1.79M

Relative Volume:

4.59

Market Cap:

$3.74B

Revenue:

$560.03M

Net Income/Loss:

$-150.66M

P/E Ratio:

-24.58

EPS:

-4.86

Net Cash Flow:

$-87.43M

1W Performance:

+6.54%

1M Performance:

+9.87%

6M Performance:

+69.01%

1Y Performance:

+6.72%

1-Day Range:

$116.25

$128.52

1-Week Range:

$110.63

$128.52

52-Week Range:

$55.92

$128.52

Irhythm Technologies Inc Stock (IRTC) Company Profile

Name

Irhythm Technologies Inc

Sector

Healthcare (1169)

Industry

Medical Devices (154)

Phone

415-632-5700

Address

699 8TH STREET, San Francisco, CA

Employee

2,000

Twitter

@iRhythmTech

Next Earnings Date

2024-10-30

Latest SEC Filings

IRTC's Discussions on Twitter

Compare IRTC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IRTC Irhythm Technologies Inc	119.44	3.74B	560.03M	-150.66M	-87.43M	-4.86
ABT Abbott Laboratories	134.92	234.01B	41.95B	13.40B	6.49B	7.65
BSX Boston Scientific Corp	104.49	154.20B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	382.78	146.06B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	89.94	115.42B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	73.30	43.23B	5.72B	4.17B	490.10M	6.97

Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-03-24	Resumed	Wells Fargo	Equal Weight
Oct-04-24	Initiated	Goldman	Neutral
Jun-20-24	Upgrade	Wolfe Research	Peer Perform → Outperform
Dec-11-23	Upgrade	Citigroup	Neutral → Buy
Jul-19-23	Initiated	Robert W. Baird	Outperform
Feb-07-23	Initiated	Wells Fargo	Overweight
Nov-07-22	Upgrade	Wolfe Research	Underperform → Peer Perform
Jun-09-22	Downgrade	Citigroup	Buy → Neutral
Apr-06-22	Initiated	Wolfe Research	Underperform
Feb-24-22	Upgrade	Needham	Hold → Buy
Jan-18-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jan-12-22	Upgrade	BTIG Research	Neutral → Buy
Jan-11-22	Upgrade	Oppenheimer	Perform → Outperform
Dec-21-21	Resumed	Canaccord Genuity	Buy
Dec-17-21	Upgrade	JP Morgan	Neutral → Overweight
Dec-15-21	Upgrade	Citigroup	Neutral → Buy
Jun-02-21	Downgrade	Citigroup	Buy → Neutral
Apr-13-21	Downgrade	BTIG Research	Buy → Neutral
Apr-12-21	Downgrade	JP Morgan	Overweight → Neutral
Feb-26-21	Downgrade	Colliers Securities	Buy → Neutral
Jan-29-21	Reiterated	Needham	Hold
Nov-17-20	Downgrade	Oppenheimer	Outperform → Perform
Sep-11-20	Initiated	Needham	Hold
Sep-02-20	Initiated	Robert W. Baird	Neutral
Aug-07-20	Upgrade	Colliers Securities	Neutral → Buy
Aug-05-20	Upgrade	Oppenheimer	Perform → Outperform
Mar-05-20	Initiated	Citigroup	Buy
Feb-06-20	Initiated	BTIG Research	Buy
Jan-10-20	Initiated	William Blair	Outperform
Jan-08-20	Initiated	SunTrust	Buy
Oct-22-19	Initiated	Oppenheimer	Perform
Feb-20-19	Downgrade	Chardan Capital Markets	Buy → Neutral
Sep-13-18	Reiterated	Canaccord Genuity	Buy
Sep-06-18	Initiated	Chardan Capital Markets	Buy
Aug-02-18	Upgrade	Dougherty & Company	Sell → Neutral
Jul-16-18	Downgrade	Dougherty & Company	Neutral → Sell
Dec-01-17	Initiated	Dougherty & Company	Neutral

View All

Irhythm Technologies Inc Stock (IRTC) Latest News

Feb 21, 2025

iRhythm Stock Hits 52-Week High at $124.45 Amid Growth Optimism - Investing.com Nigeria

Feb 21, 2025

iRhythm stock rises on Q4 results, on-target FDA remediation efforts - Mass Device

Feb 21, 2025

Truist Securities raises iRhythm stock target to $145, maintains Buy By Investing.com - Investing.com UK

Feb 21, 2025

iRhythm stock rises on strong Q4 results and outlook By Investing.com - Investing.com Canada

Feb 21, 2025

iRhythm Stock Hits 52-Week High at $124.45 Amid Growth Optimism By Investing.com - Investing.com South Africa

Feb 21, 2025

iRhythm Technologies, Inc. (NASDAQ:IRTC) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 21, 2025

Breaking Down iRhythm Technologies: 6 Analysts Share Their Views - Benzinga

Feb 21, 2025

iRhythm targets $675M-$685M revenue for 2025 driven by Zio adoption and international expansion - MSN

Feb 21, 2025